Ethex extends recall of oversized tablets
This article was originally published in Scrip
Executive Summary
KV Pharmaceutical's Ethex generics division has expanded its recall of medicines that may contain oversized tablets with twice the intended level of active ingredient. Last month the company recalled three lots of dextroamphetamine 5mg tablets. The recall has now been extended to multiple lots of propafenone HCl 150mg, 225mg, and 300mg tablets; isosorbide mononitrate extended-release 30mg and 60mg tablets; morphine sulphate extended-release 15mg tablets; morphine sulphate immediate-release 15mg and 30mg tablets; and dextroamphetamine sulfate 10mg tablets. The products are being recalled to the consumer level, and Ethex is instructing pharmacies to contact consumers who were dispensed the drugs for replacement and/or refund.